UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of November 2025
Commission File Number: 001-42213
WeRide Inc.
21st Floor, Tower A, Guanzhou Life Science
Innovation Center
No. 51, Luoxuan Road, Guangzhou International
Biotech Island
Guangzhou 510005
People’s Republic of China
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form 20-F x Form 40-F ¨
EXPLANATORY NOTE
WeRide Inc. made an announcement dated November 12,
2025 with the Stock Exchange of Hong Kong Limited in relation to the date of board meeting. For details, please refer to the exhibits
to this current report on Form 6-K.
EXHIBIT INDEX
| Exhibit No. |
|
Description |
| 99.1 |
|
Announcement – Date of Board Meeting |
| |
|
|
| 99.2 |
|
Press Release |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| |
WeRide Inc. |
| |
|
|
| |
By: |
/s/ Jennifer Li |
| |
Name: |
Jennifer Li |
| |
Title: |
Chief Financial Officer |
Date: November 12, 2025
